What is Nebzmart BL Smartules 2ml

Nebzmart BL Smartules 2ml is a combination nebulizer inhalation suspension containing FDA-approved active ingredients Levosalbutamol (1.25 mg) and Budesonide (0.5 mg). Glenmark Pharmaceuticals Ltd manufactures Nebzmart BL Smartules 2 ml in GMP-compliant facilities under strict quality standards.

Levosalbutamol is a selective beta-2 adrenergic bronchodilator, and Budesonide is an inhaled corticosteroid. Together, they are used to manage conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD). The combination of rapid bronchodilation from Levosalbutamol and sustained anti-inflammatory control from Budesonide makes the smartules effective for both the immediate management of airway narrowing and the long-term prevention of symptom recurrence.

It is administered using a jet nebulizer, which converts the liquid suspension into a fine, breathable mist that is inhaled directly into the lower airways. Each single-dose smartule contains a pre-measured 2 ml of suspension, eliminating the need for manual dose preparation before each nebulization session.

This format is particularly beneficial for children, elderly patients, or those who are unable to use handheld inhalers effectively due to difficulty generating adequate inspiratory force or coordinating breath with actuation. However, it can cause side effects like headache and cough.

It is also not suitable for pregnant and breastfeeding women or those allergic to Levosalbutamol and Budesonide. To maintain efficacy, the respules should be stored in a cool and dry area, below 30°C, away from direct sunlight and heat.

What are the benefits of taking Nebzmart BL Smartules 2 ml

Nebzmart BL Smartules 2 ml offers a clinically effective dual-action approach to managing obstructive respiratory conditions through regular nebulizer therapy. Some of its benefits include:

• Rapid bronchodilation: Levosalbutamol acts quickly on beta-2 receptors in the bronchial smooth muscle, relaxing the airways and relieving breathlessness, wheezing, and chest tightness within minutes of nebulization.
• Sustained airway inflammation control: Budesonide suppresses the inflammatory mediators driving chronic airway swelling and mucus overproduction, reducing the frequency and severity of respiratory symptoms with consistent use over time.
• Dual-action in a single dose: The combination of a bronchodilator and a corticosteroid in one smartule eliminates the need for separate nebulization sessions for each medication, simplifying the treatment regimen and improving adherence.
• Suitable for patients unable to use conventional inhalers: The nebulizer format ensures effective medication delivery for young children, elderly patients, and individuals whose condition prevents adequate use of pressurized or dry powder inhalers.

How to take Nebzmart BL Smartules 2ml

Nebzmart BL Smartules 2 ml is a prescription medication that should be used as directed by a healthcare professional. Here are the general guidelines:

• Use Nebzmart BL Smartules two to three times daily or as prescribed.
• Twist open a single smartule and empty the entire contents into the jet nebulizer chamber. Breathe in the mist steadily through the mouthpiece or face mask until the chamber is empty, which usually takes 5 to 10 minutes.
• Rinse the mouth thoroughly with water after each nebulization session and spit it out to prevent Oral Candidiasis (thrush) from the inhaled corticosteroid component.
• Do not exceed the prescribed dosage. Do not mix with other medications in the nebulizer chamber unless specifically directed by a doctor.

Strengths and Substitutes

Nebzmart BL Smartules are available only in a single-strength formulation. However, you can consider the following effective substitutes:

View all substitutes

What are the side effects of Nebzmart BL Smartules 2 ml

Like any medication, Nebzmart BL Smartules 2 ml can cause mild side effects that generally subside as the body adjusts to the treatment. However, consult a healthcare professional if any of these persist or worsen:

• Tremors or shakiness
• Palpitations or increased heart rate
• Throat irritation or hoarseness
• Oral Candidiasis if the mouth is not rinsed after use
• Headache
• Coughing after inhalation
• Nausea

Safety Advice

Liver Disease

Patients with liver disease should use Nebzmart BL Smartules 2 ml with caution. Budesonide is extensively metabolized in the liver, and impaired liver function can reduce its clearance, leading to increased systemic exposure and a higher risk of corticosteroid-related effects. Although these effects are minimal in inhaler medicines, inform a doctor of any liver conditions before beginning treatment.

Kidney Impairment

Nebzmart BL Smartules 2 ml should be used with caution in patients with kidney disease. While inhaled medications have low systemic absorption, Levosalbutamol can cause electrolyte disturbances, which can be of concern in people with compromised kidney function. Inform a doctor of any existing kidney conditions before starting this medication.

Pregnant and Breastfeeding women

Budesonide and Levosalbutamol smartules should be used during pregnancy only when clearly necessary and under medical supervision. Both Budesonide and Levosalbutamol can pass into breast milk in small amounts. Pregnant and breastfeeding mothers should discuss the benefits and risks with a doctor before continuing or initiating treatment.

Avoid

Do not use Nebzmart BL Smartules 2 ml in the case of known hypersensitivity to Levosalbutamol, Budesonide, or any inactive ingredients in the formulation. Avoid use with an ultrasonic nebulizer, as it may make Budesonide inactive. Do not use this medication as a substitute for a short-acting rescue bronchodilator during an acute, severe asthma attack unless instructed by a doctor.